Adherence With Iron Sprinkles Among High-Risk Infants
Completed
Centers for Disease Control and Prevention
Phase 3
2005-03-01
Compared with iron drops, iron sprinkles supplied for 3 months to high-risk children
beginning at age 5-7 months will increase adherence and reduce the rates of anemia and iron
deficiency.
A Pilot Study of Topiramate in Childhood Absence Epilepsy
Completed
Ortho-McNeil Neurologics, Inc.
Phase 2
2005-03-01
Limited data exist on the effectiveness of antiepileptic drugs for treatment of childhood
absence epilepsy. Preliminary data suggest that topiramate may be an effective drug for this
condition. The present study is designed to provide further evidence of the potential
effectiveness of topiramate for childhood absence epilepsy, as well as preliminary
information about a potential target dose for future study.
A Pilot Study of Topiramate in Childhood Absence Epilepsy
Completed
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Phase 2
2005-03-01
Limited data exist on the effectiveness of antiepileptic drugs for treatment of childhood
absence epilepsy. Preliminary data suggest that topiramate may be an effective drug for this
condition. The present study is designed to provide further evidence of the potential
effectiveness of topiramate for childhood absence epilepsy, as well as preliminary
information about a potential target dose for future study.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
